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This consensus guideline discusses the electrocardiographic phenomenon of beat-to-beat QT interval variability (QTV) on surface electrocar-
diograms. The text covers measurement principles, physiological basis, and clinical value of QTV. Technical considerations include QT interval
measurement and the relation between QTV and heart rate variability. Research frontiers of QTV include understanding of QTV physiology,
systematic evaluation of the link between QTV and direct measures of neural activity, modelling of the QTV dependence on the variability of
other physiological variables, distinction between QTV and general T wave shape variability, and assessing of the QTV utility for guiding therapy.
Increased QTV appears to be a risk marker of arrhythmic and cardiovascular death. It remains to be established whether it can guide therapy
alone or in combination with other risk factors. QT interval variability has a possible role in non-invasive assessment of tonic sympathetic
activity.
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Introduction
In 2014, the European Heart Rhythm Association (EHRA) together
with the ESC Working Group on Cardiac Cellular Electrophysi-
ology charged the authors of this text with reviewing the topic of
beat-to-beat QT interval variability (QTV) to provide a consensus
guideline concerning its measurement, physiological background,
and clinical utility. In addition to the review of the topic, the text pro-
vides recommendations highlighted in italics.
The RR interval measured from body surface ECG exhibits spon-
taneous beat-to-beat changes, usually termed heart rate (HR) vari-
ability (HRV), and related to sinus nodal autonomic control.1 The
QT interval also exhibits spontaneous beat-to-beat fluctuations, re-
flecting subtle temporal variations in ventricular depolarization and
repolarization. These are termed QTV and usually monitored sim-
ultaneously with HRV. Under normal resting stable HR conditions,
QTV is small (2–3 magnitudes smaller than HRV), with a standard
deviation typically below 5 ms (Figure 1).2 Assuming that ventricular
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depolarization is much more stable compared with the beat-to-beat
changes in repolarization duration, QTV is understood to measure
the variability of ventricular repolarization duration. Despite some
relation, QTV differs from T wave variability3 or alternans,4 which
deal with beat-to-beat changes in the T-wave amplitude and
morphology.
Methodology
Measurement principles
QT interval measurement
Under normal conditions, beat-to-beat QT interval changes are
minimal, detectable by computerized high-resolution ECG. Accur-
ate delineation of T wave end (Tend) is challenging, and most com-
mercial systems measure the average, rate-corrected QT interval,
and QT dynamicity, utilizing simple tangent and threshold methods.5
Although such techniques were used for QTV analysis,6 –10 their ac-
curacy appears insufficient and other QT delineations should be
considered.11
Dedicated QTV measurement techniques match complete or
partial ECG waveforms with one or several templates, either user-
defined or automatically computed. Since Tend in a given ECG lead
does not necessarily correspond to the true repolarization end, in-
formation beyond the lead-specific QT interval needs to be consid-
ered on scalar ECG.
In all consideration on QTV, it needs to be also recognized that
measurement of the duration of the QT interval does not utilize
the information within the T wave itself. Morphological beat-to-
beat T wave changes that also represent repolarization variability
should also be considered in repolarization variability analysis.
Nevertheless, as this text deals solely with QTV, no further refer-
ences to the morphological and other changes within the T wave
are made.
The most commonly used algorithm matches the stretched or
compressed ST-T segments of consecutive beats with a user-
defined template, obtaining ST-T segment duration changes relative
to the template duration.12 The QRS interval is assumed constant.
Naturally, this is not always fully accurate as rate-dependent changes
in activation sequence also exist. Variation in the metrics used for
template matching might thus also be erroneously interpreted as
primary repolarization variation when in fact secondary variations
due to the activation sequence modulations should also be consid-
ered. Time matching a template of the T wave descending part with-
in consecutive beats together with beat-to-beat Q onset detection
was also proposed.13 Recently, a matching algorithm based on two-
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Figure 1 Example traces of RR (left) and QT intervals (right) of a normal subject (A) in comparison to a patient following MI (B), demonstrating
augmented beat-to-beat QT variability after MI despite the reduction in HRV (unpublished data).
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dimensional warping of the entire QT interval was introduced.14
Fiducial segment averaging is an alternative basic template matching
approach.15 Operator’s choice of the template duration appears
to have a low impact on measurement reproducibility results16
and it has been reported that both inter- and intra-operator vari-
ability is low.17 Automated template generation may improve
reproducibility.13
Using robust, (semi-)automated template matching techniques for QTV
analysis is recommended.18
ECG lead and T wave amplitude
Temporal QT interval variations may differ between recording sites
reflecting local repolarization signal heterogeneity, lead-specific res-
piration effects and noise (e.g. myopotentials).19 Short-term QTV
analysis of 12-lead ECG suggests considerable inter-lead differ-
ences.20 Short-term QTV from ambulatory ECG showed significant
differences between the lateral and septal/anterior leads.21 Non-
significant QTV difference between leads I, AVF, and V2 and
moderate correlations were reported in patients undergoing elec-
trophysiological study.22 Larger respiration-related cardiac axis
movements were suggested in Z lead RTpeak measurements com-
pared with X and Y leads.23 The T wave amplitude may influence
QTV (Figure 2). Leads with tall T waves and high signal-to-noise ratio
typically yield lower QTV.2,20 Conversely, flat T waves decrease
certainty of Tend determination, leading to increased variability.
QT interval variability was inversely related to the T wave amplitude
in some,18,20 but not in all studies.24
Using simple measurement algorithms should be considered with
caution. For instance, fluctuations in T wave amplitude, even in the
setting of seemingly identical morphology, may lead to fluctuations
in time of steepest T downstroke which in turn may lead to fluctua-
tions in tangent method determination of Tend. Observed variation
in Tend may then have little to do with repolarization variation.
The dominant singular value decomposition component of multi-
lead ECG was proposed for QTV analysis.25 Information on spatial
repolarization heterogeneity may be gained by measuring QTV dif-
ferences across leads.22 Regional pathology-driven differences in
ventricular repolarization may be reflected in QTV differences
across leads.19
In single-lead QTV analysis, lead II may be recommended allowing
study-to-study comparisons.2 Alternatively, QTV may be analysed in the
lead with the tallest T wave. QT interval variability should be reported
in relation to the T wave amplitude and noise levels. Multi-lead QTV ana-
lysis warrants further investigation.
The interpretation of single-lead QTV studies needs also to reflect the
fact that the QT interval in a given lead only measures the interval be-
tween the earliest depolarization and latest repolarization as projected
onto the axis of that lead. There is no information contained in the meas-
urement relating to localizing where along that axis the earliest depolar-
ization or latest repolarization tissue resides.
RTpeak vs. QTend measurement
Earlier studies and those using Holter ECGs utilized RTpeak interval
to measure repolarization variability26– 30 because of relatively easy
automated detection and lesser susceptibility to broadband noise
compared with RTend measurements.
23 Comparison between
RTpeak and RTend variability suggests that HRV affects primarily
the variability of the early T wave portion.23 In normal subjects,
QTpeak variability is significantly correlated with QTend variability,
but this correlation appears reduced in cardiovascular disease.31
Compared with RTend, RTpeak interval is more sensitive to periodic
noise.23
Tpeak is lead dependent and influenced by the cardiac axis movement.
The descending T wave limb is believed to carry important information on
repolarization heterogeneity. Therefore, QTV measurement without the
exclusion of the Tpeak2Tend interval is recommended.
Rate correction of the QT interval and QT dynamicity
Most QTV studies have not considered HR correction, while some
introduced only the QT interval dependence on the previous RR
interval, assessed the QT–RR coupling in the frequency do-
main,26– 28 or used generic rate correction formulae.32 More recent
approaches account for the QT dependence of the sequence of pre-
ceding RR intervals33 and additional influences (e.g. respiration).34
As the QT–RR relationship varies among individuals, generic cor-
rection formulae may be problematic. Individual-specific correction
formulae that also take into account hysteresis effects have been
proposed to measure QT dynamicity,35,36 but a framework for
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Figure 2 Inverse relation between T wave amplitude and QT variability. Data were obtained from 2-min, 12-lead ECG of 69 healthy subjects.20
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QTV analysis is lacking since separating rate-driven QTV from
genuine fluctuations in QT interval is technically challenging. The
most direct solution is to study QTV at constant HR. Since cardiac
pacing is usually not feasible, several techniques have been proposed
to achieve relative HR stability and to limit cardiac cycle dependency
of QT changes during physiological conditions.37 Strategies based
on heart period binning, however, do not account for the
beat-to-beat dynamical QT–RR relation (i.e. the dependence of
the QT–RR relation on the history of the RR changes) and provide
only static estimates of the QT–RR relationship, unless hysteresis is
incorporated.38 A method that combines the binning approach and
instantaneous QT changes is under evaluation.39
Until a thoroughly and independently validated method for separating
QTV from HR is available, it can be recommended to report QTV
uncorrected for HR together with HR (besides commonly used QTV–
HRV ratios) and to study QTV under the stable HR conditions.
QT interval variability markers
Table 1 summarizes commonly used QTV measures. Most authors
report standard deviation (SDQT) or variance of QTV (QTvar).8,13
QT interval variance normalized to the squared mean QT interval
(QTVN)12 and Poincare´ plot-based, short-term variability have
also been reported.40,41 QT interval variability-to-HRV ratios are of-
ten calculated, the QT variability index (QTVi) being most popular
(Table 1).12,39,42–47
More recently, QTVi calculation based on the Tpeak–Tend interval
has been suggested.48 Other QTV-to-HRV ratios include the stand-
ard deviations of QT to RR intervals,8 the short-term variability of
QT (STVQT) to that of RR (STVRR) ratio (VR) assessed from the
Poincare´ plots.41 Although the rationale of all these indexes is the
same (i.e. normalizing QTV for HRV), the ratios differ, rendering
across-studies comparisons difficult. Importantly, physiological evi-
dence of a general proportional relationship between QTV and
HRV is lacking. Rather than separating genuine QTV from the
HRV influence, these ratios are composite measures of partially cor-
related QTV and HRV variables.
Frequency domain analysis of QTV demonstrated oscillations
related to respiratory rhythm and Traube–Hering–Mayer waves
(Figure 3).26 – 28 Squared coherence quantifies QT-RR coupling as
a function of frequency,12,26,29,49,50 demonstrating significant asso-
ciations both in the low (LF, 0.04–0.15 Hz) and high frequencies
(HF, 0.15–0.4 Hz) (Figure 4).1 Thus, LF and HF rhythms in QTV
are at least in part a reflection of QT rate adaptation.26,27,29 Transfer
function analysis with HRV as input and QTV as output was utilized
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Commonly used variables of beat-to-beat QT interval variability
Variable Units Description
QT variability
SDQT ms Standard deviation of QT intervals; SDQT =
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
1
N
∑
(QTn − QTmean)2
√
QTVN du Normalized QT interval variance; QTVN = SDQT
2
QTmean2
STVQT ms Short-term QT interval variability; STVQT =∑ |QTn+1−QTn |
N
NameMe
2
√
LTVQT ms Long-term QT interval variability; STVQT =∑ |QTn+1−QTn−2QTmean|
N
NameMe
2
√
QT variability normalized to HRV
QTVi du QT variability index; QTVi = log QTVN
HRVN
or QTVi = log QTVN
RRVN
VR du Variability ratio; VR = STVQT
STVRR
Frequency domain markers of QTV and QT–RR variability interactions
QTVLF ms
2 Power of QTV assessed in LF band (from 0.04 to 0.15 Hz)
QTVHF ms
2 Power of QTV assessed in HF band (from 0.15 to 0.5 Hz)
|Hqt−rr| du Transfer function gain from RRV to QTV; |Hqt−rr|(f ) = |Cqt−rr(f )|Srr(f )
fqt−rr rad Cross-spectrum phase from RRV to QTV; fqt−rr(f ) = phase of Cqt−rr(f )
K(qt−rr)2 du Squared coherence between RRV and QTV;
K(qt−rr)2 (f )= |Cqt−rr(f )2
Srr(f )Sqt(f )
Time domain QTV decomposition
RR-related QTV ms2 QTV linearly related to RRV
RR-unrelated QTV ms2 QTV linearly independent of RRV
Normalized RR-related QTV du Percentage of QTV linearly related to RRV
Normalized RR-unrelated QTV du Percentage of QTV linearly independent of RRV
du, dimensionless units; LF, low frequency; HF, high frequency; N, number of beats; HRvar, variance of HR time series; RRvar, variance of RR time series; HRVN ¼ HRvar/HRmean2 ;
RRVN ¼ RRvar/RRmean2 .; RRV, RR interval variability; Srr, RRV power density spectrum; Sqt, QTV power density spectrum; Cqt-rr, cross-spectral power density between QTV and
RRV.
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to estimate the gain and the phase of the QT–RR relation as a fre-
quency function (Figure 4).26,28,29 More complex approaches of
multivariate linear modelling and partial process decomposition
quantify the amount of QTV driven by the variability of determi-
nants (e.g. QTV driven by HRV, respiration).29,34 An example of
this decomposition is shown in Figure 5. (See also Appendix A)
More recently, non-linear dynamical systems and information theor-
ies have been adopted to quantify QTV (Appendix B).
Comparative studies identifying redundancies in QTV indices are
needed. If composite measures are used, QTV and HRV should also be
reported, including multivariable analyses to distinguish QTV and HRV
contributions in a given clinical setting. Given the complexity and non-
linearity of the QT-HR relation, simple linear QTV-HRV relationships
should be considered with caution. Frequency domain parameters have
so far been insufficiently explored. Their further research in clinical settings
is warranted.
Reproducibility studies
Short-term QTV measured randomly across 24-h ECG suggests
better reproducibility compared with HRV, with a coefficient of
variation (CV) of 0.22.22 Reproducibility analysis of QTV obtained
from 24-h ECG on three different days showed a CV of SDQT,
0.14.8 A reproducibility study of short-term QTVi obtained during
different days reported coefficients of variation of 0.18 in healthy
subjects and of 0.40 in end-stage renal disease patients.17
Month-to-month and year-to-year analysis of QTVi derived from
short-term ECG in healthy subjects demonstrated coefficients of
variation of 0.08 and 0.09, respectively.51 Comparison of short-term
ECG recorded in the supine position vs. sitting resulted in a CV of
0.12.51 As QTV is affected by autonomic activity, temporal transition
across autonomic states might adversely affect reproducibility in
longer recordings.52 STVQT may therefore be better reproducible
than QTvar.53
Only few studies on QTV reproducibility are available. More focused
research is needed.
Technical aspects influencing the QT
interval variability markers
ECG acquisition requirements
ECG acquisition and pre-processing have not been standardized in
QTV studies. Effects of filtering and digitizing require thorough in-
vestigation. A systematic comparison of sampling rates demon-
strated that 500 Hz are sufficient while sampling rates of 200 Hz
and below may artificially increase QTV values.54 Theoretical inves-
tigation of digitization noise and simulation studies also suggests that
500 Hz is a sufficient sampling rate for QTV measurement.55 High
pass cut-off frequency of 0.05 Hz may be recommended. Using high-
er high pass cut-off frequencies, e.g. to reduce baseline wander, may
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significantly distort T morphology possibly if not likely affecting Tend
measurement. Sufficiently fine gain resolution is needed to avoid the
‘staircase’ effect on the digitalized T waves.
Studies investigating the effect of low T wave amplitude on QTV and
establishing the minimum gain resolution (in relation to T wave ampli-
tudes) are needed.
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Recording duration
Most QTV studies have used short-term ECG, typically 256–512 s
durations or 256–512 beats, adopting the time frame recom-
mended for short-term HRV analysis.1 QT-RR hysteresis may intro-
duce transient changes. Caution is thus warranted when inferring
stationarity of short-term QTV based on seemingly stationary HR.
To deal with this issue, detrending of QT time series has been pro-
posed.12 QT interval variability over longer durations, capturing di-
urnal or circadian cycles, has also been reported. However, in most
cases, recordings were divided into short relatively noise-free seg-
ments and analysed separately.7,8,10,56,57,58 Longer recordings have
been frequently utilized for non-linear analyses.59
There is little data to guide time frame choices for QTV analyses.
Systematic investigations are needed.
Effects of ECG artefacts
Template matching techniques deal with broadband noise better than
traditional QT measurement techniques.18 However, they are
susceptive to low frequency noise with periods similar to template
duration.2 Baseline wander may add further noise to QTV measure-
ment,2,18,23 but its influence depends largely on methods for its
removal. ECG amplitude modulation and spatial rotation due to re-
spiratory cardiac axis movement is another source of measurement
noise.23 Its effect on QTV was reported to be small,18 but significant
when axis movement is considered.60 A minimum signal-to-noise ra-
tio of 15 dB was found necessary for QTV analysis.61
Quantitative procedures should be specifically designed to evaluate and
reduce the effect of ECG artefacts on the QTV computation.
Unless a study nature dictates different conditions, QTV investigations
should include (but not necessarily be restricted to) measurements
made in ECGs recorded is supine position so that different reports can
be compared.
Ectopic beats
Ectopic beats are excluded in studies of repolarization instability fol-
lowing regular ventricular conduction.22 As premature ventricular
contraction itself may trigger ventricular tachycardia/fibrillation
(VT/VF), inclusion of ectopic beats in the overall QTV assessment
has been proposed.62 Recently, QTV before and after premature
ventricular contraction was found to predict non-sustained VT in
chronic heart failure (CHF) and an increased VT/VF risk.63 Post-
ectopic QT patterns may be linked to baroreflex response.64
Ectopic and subsequent beats should be excluded from QTV assess-
ment. The QT response to ectopic beats may be analysed separately
and deserves further investigation.
Technical recommendation
QT interval variability (with no HR correction) should be measured over
the entire QT interval in lead II or in the lead with the tallest T wave using
high-resolution ECGs recorded at .500 Hz at steady HR. Studies are
required to compare (i) consistency across available QTV measurement
algorithms and metrics, (ii) reproducibility, and (iii) recording duration.
Physiological basis of QT interval
variability
QT–heart rate relationship
In resting conditions, HRV is a major physiological source of QTV.65
The QT interval is linked to HR through the cellular dependency of
action potential duration (APD) on cycle length.66 The QT response
to RR changes comprises rapid and slow processes67,68,69,70 result-
ing in significant hysteresis effects.71 Figure 6 illustrates the QT inter-
val response to different rates of cardiac pacing and demonstrates
residual QTV. The relation between QT interval and HR follows
individual-specific, well-reproducible curvatures.72 Basic physio-
logical manoeuvres such as orthostatic challenge reveal
acceleration-/deceleration-dependent hysteresis of the QT interval
response to HR.73 Cardiac pacing sequences may also affect the
QT–RR relationship.74 Although the QT–RR relation is crucial to
QTV, the dynamical response of QT to RR changes under spontan-
eous conditions remains largely unknown.
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Figure 6 Example traces of RR (in red) and QT intervals (in green) in a patient during spontaneous sinus rhythm and during right atrial pacing at
different rates, illustrating the rate adaption of the QT interval and residual QT variability in the absence of RR interval variability (unpublished
data).
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Further studies of the effects of the QT–HR relationship on QTV are
needed, both in stationary and in non-stationary HR conditions. Until
the effect of HR changes is better understood, QTV should be evaluated
at steady HR.
Cellular mechanisms
Variation in QT duration at a constant RR interval is caused by
beat-to-beat variability of the overall ventricular repolarization
(BVR). Two factors potentially alter repolarization on a beat-to-beat
basis: (i) variation in ventricular activation pattern and/or conduc-
tion velocity and (ii) variation in ventricular APD. To date, research
has focused on mechanisms underlying variation in the duration and
morphology of myocardial repolarization, as evidenced by mono-
phasic action potential recordings from the ventricular surface/
endocardium, transmembrane recordings from transmural ventricu-
lar wedge preparations, and microelectrode recordings from single
isolated myocytes.75,76,77,78,79
APD is determined by the magnitude and time course of voltage-
and time-dependent ionic currents. The primary outward currents
are carried by K+ ions through distinct channel types, the rapidly and
slowly activating delayed-rectifier potassium channels (IKr and IKs),
and the transient outward (Ito), and inward rectifier potassium chan-
nels (IK1). Inward currents, in particular the late Na
+ current
(INaLate) and Ca
2+ current (ICa,L), also determine the APD. In add-
ition to this, there are ionic currents modulated by intracellular
Ca2+, including the Ca2+-activated Cl2 current (ICl,Ca), ICa,L and
Na+/Ca2+ exchanger (NCX), which allows beat-to-beat changes
of intracellular Ca2+ to contribute to BVR. Myocardial metabolic
status can also indirectly influence APD rapidly via ion channels con-
trolled by metabolites, e.g. the ATP-sensitive K+ channel (KATP) or
by extracellular conditions, e.g. K+ and H+ concentration changes
that result from changes in tissue perfusion. While unstable tissue
perfusion characteristics may contribute to BVR, this has not been
demonstrated experimentally.
The situation is further complicated by the direct and rapid
modulation of APD via restitution in which a shortened diastolic
interval limits the reactivation of inward currents and the inactiva-
tion of outward currents, thereby decreasing the proceeding
APD. The shape and slope of this relationship critically affect the sta-
bility of APD. If the relationship between diastolic interval and the
next APD has a shallow slope of,1, minor perturbations of diastol-
ic interval cause only a transient APD variation before the steady
state is restored. Theoretically, with the slope of this relationship
.1, a sustained beat-to-beat APD variation occurs. However, the
resulting pattern is stable APD alternans;80 hence, a monophasic de-
pendence of APD on diastolic interval cannot alone explain BVR.
However, more complex (e.g. bi- and tri-phasic) relationships
have been reported,81 predicting complex relationships between
APD and RR interval that could contribute to BVR. A recent study77
investigated APD, APD alternans, and BVR in canine ventricular
myocytes, and found that alternans and BVR are clearly different
in their dependency on rate and their connection to mechanical al-
ternans, indicating distinct ionic mechanisms. At slow pacing rates,
the potassium current IKs stabilizes BVR, despite minimal changes
in APD. b-Adrenergic stimulation of IKs rescues from excessive re-
polarization instability and the generation of early after depolariza-
tions. These data also show that under specific conditions it is
possible to dissociate APD and BVR, e.g. during IKs blockade com-
bined with b-adrenergic stimulation (with or without intracellular
Ca2+ buffering). Spontaneous release of Ca2+ from the sarcoplas-
mic reticulum during diastole can influence the subsequent APD
through decreasing the inactivation time course of ICa,L, resulting
in a longer APD.76 The spontaneous Ca2+ release event is known
to be a variable process on a beat-to-beat basis and therefore under
conditions of excessive sarcoplasmic reticulum Ca2+ loads, the vari-
able process of spontaneous diastolic Ca2+ release provides a
mechanism for BVR at the single myocyte level.76 However, it is un-
clear whether this mechanism can operate at the multicellular level
where events in a single cell have negligible effect due to electrical
coupling in the syncytium. In theory, the random nature of diastolic
Ca2+ release will operate both temporally and spatially, and thus,
the overall effect on ventricular APD will be minimized and would
not be expected to generate BVR. On the other hand, recent re-
ports suggest that spontaneous Ca2+ release in one cell can trigger
release in adjacent cells.82 Therefore, under conditions of increased
sarcoplasmic reticulum Ca2+ load, significant regions of myocar-
dium may experience co-ordinated waves of spontaneous diastolic
Ca2+ release83 and therefore prolonged APD of the subsequent
beat. This remains to be demonstrated experimentally. The link be-
tween intracellular Ca2+ and BVR is further supported by the evi-
dence from in vivo studies that increased sympathetic activity,
which raises intracellular Ca2+ levels, is associated with increased
QTV. In an in vivo dog model of long QT1 syndrome,84 QTV and
BVR of the left ventricular monophasic APD were increased just
prior to torsades de pointes. This repolarization instability was al-
ways accompanied by sizeable systolic after contractions, which
also suggests a role of Ca2+ and/or mechanically evoked arrhythmo-
genesis. Isolated heart work indicated that local activation of
b-adrenergic receptors can cause sufficient Ca2+ overload within
a discrete area to trigger a ventricular ectopic beat.79
Although the cellular basis is not fully understood, the current evidence
suggests that spontaneous sarcoplasmic reticulum Ca2+ release is a likely
cellular mechanism for BVR and subsequent QTV. More generally, it is re-
cognized that although single myocyte BVR is clearly not the sole contribu-
tor to in vivoQTV, insights into the ionic mechanisms of BVR are crucial for
the understanding of BVR at the whole organ level.
Stochastic ion channel properties
Isolated myocytes display intrinsic beat-to-beat APD variability pro-
portional to APD duration that increases when blocking ICa,L and
Ito.
85 Stochastic fluctuations in IKs gating property have been shown
to cause significant beat-to-beat APD variability in isolated cells.86
Stochastic gating of INa, ICa,L, and IKr currents has also been impli-
cated in APD variability.87,88 In the tissue, however, inter-cellular
electrotonic interactions reduce the effect of stochastic gating.89
Conditions with reduced repolarization reserve and gap junction
decoupling may augment the effect of stochastic ion channel gating.
Experimental evidence and computer simulations are needed to ex-
plore stochastic ion channel gating effects on QTV in body surface ECG.
Autonomic nervous system
The autonomous nervous system affects cardiac repolarization vari-
ability at cellular, tissue, and organ levels. b-Adrenoceptor stimula-
tion during IKs block has been shown to increase variability of
M. Baumert et al.Page 8 of 20
by guest on January 28, 2016
D
ow
nloaded from
 
cellular repolarization of canine myocytes.77 Transmural differences
in APD affect T wave morphology90 and may be altered through
b-adrenergic activation.91 The same applies to other intramyocar-
dial gradients. Heterogeneous distribution of b-adrenoceptors, re-
gional arborization of sympathetic nerves,92,93 and differential
cardiac sympathetic control66 may contribute to spatial APD het-
erogeneity across the ventricles during high-sympathetic activity.
Vagal nerve activity may alter ventricular APD directly via the
ACh-activated K+ current94 or indirectly through accentuated antag-
onistic effects on the sympathetic nerve, pre- and post-synaptically.95
Postural provocations in man have been shown to increase vari-
ous measures of QTV and QTVi in the majority,16,49,54,96,97 but not
in all studies.98 Inconsistencies might have resulted from age-related
QTVi increases.97 Similarly, hypoxia-induced sympatho-excitation
increased QTVi and QTVN.99 Spectral analyses of QTV during
mental stress test during atrial pacing,100 interview stress, and exer-
cise101 all suggest an increase in LF oscillations during sympathetic
activation. QT variability index was also shown to increase during
exercise,102,103,104 while QTVN showed inconsistent increase.103
Sympathetic activation by caffeine resulted in higher QTVi during
REM sleep.105 Pharmacological b-adrenoceptor activation consist-
ently increases QTV,16,99,106,107 while b-adrenoceptor block has
shown no effect on QTV during rest,98,106 but a reduction during at-
rial pacing in patients with structurally normal hearts.9 Ambulatory
RTpeak analysis has shown a reduction in variability after
b-adrenoceptor block.26 Pharmacological a1-adrenergic receptor
activation did not affect QTVi or QTVN.99 Comparing QTV with
direct measures of cardiac sympathetic activity, cardiac norepineph-
rine spillover showed no correlation during rest.108 Similarly, QTVi
was correlated with electrodermal activity during exercise, but not
during rest,102 and QTVi was not correlated with cardiac sympa-
thetic nerve activity in healthy dogs.109 This all suggests QTV in-
crease due to sympathetic activation in normal subjects. At rest,
sympathetic outflow to the heart may be insufficient to elicit QTV.
Investigations of the relation between absolute levels of sympathetic ac-
tivity (tone) and QTV in healthy subjects are encouraged to establish
whether changes of QTV quantify absolute sympathetic activity directed
to the heart. A clinical protocol of QTV assessment may include an ortho-
static challenge. Simultaneous recording of surface ECG and intra-cardiac
electrograms may elucidate the QTV proportion linked to sympathetic in-
nervation heterogeneity. The relation between sympathetic activity and
QTV in pathological cardiac substrate requires further investigation.
Respiration
Respiration may influence QTV through respiratory sinus arrhyth-
mia,110 APD modulation of ventricular myocytes,111
mechano-electrical feedback to changes in ventricular loading112
and by measurement artefacts in single leads due to cardiac axis ro-
tation.60 Respiration also affects T wave amplitude with likely impli-
cations on simple algorithms of QT measurement.
Most studies on the effect of respiration on repolarization vari-
ability have been performed using the RTpeak interval, which may
not be extrapolated to QTV. Spectral analysis of RTpeak variability
in patients with structurally normal ventricles during sinus rhythm
demonstrated HF oscillations in QTV directly related to HRV since
no significant direct QTV influence of respiration was observed dur-
ing fixed atrial pacing and autonomic blockade.30 Another study of
RTpeak variability during fixed atrial pacing suggested small
respiratory-related changes due to cardiac axis rotation,27 consist-
ent with the use of a spatially derived respiration-compensated
lead for QTV assessment.60 A small direct, HR-unrelated effect of
respiration on QTV was detected during spontaneous breathing
with graded head-up tilt, independent of the orthostatic chal-
lenge.23,34 Data suggest that the HR-unrelated contribution to
respiratory-related RTpeak variability is negligible.
Metronomic breathing at various rates showed no difference in
QT variance in normal subjects in the supine position and during
standing compared with free breathing16 or in CHF patients.97 How-
ever, increased power and gain in the HF band of the RR–RTpeak se-
quence was observed in normal subjects during metronomic
compared with free breathing.7,29
QT interval variability measurement during spontaneous breathing is
recommended if basic time domain metrics are considered. Metronomic
breathing may be preferable for frequency domain analyses. Derived
ECG leads compensated for cardiac axis rotation warrant further
investigation.
Other factors influencing QT interval
variability in normal subjects
Circadian influences
In normal subjects, QTV appears to be lower during night time com-
pared with day time,8,10,26,113,114,115 supporting the QTV link with
cardiac autonomic tone.116,117 Lower recordings noise during night
as well as lower HR might also play a role.
Age
Data on QTV age dependency are inconclusive. SDQT obtained in
ambulatory ECG91,94 and short-term ECG20 were reported com-
parable between younger and older adults, while other studies
found reduced118 or increased98 QTV. QT variance obtained
from ambulatory ECG was not different between children and
adults,119 while short-term QT variance was found increased in chil-
dren,56 but comparable across children of different ages.120
Most,97,118,120,121,122 but not all,56 studies report the QTV/HRV ra-
tio to increase with age, which may primarily be a reflection of the
well-known age-related HRV reduction.
Sex
Ambulatory and pre-exercise ECG studies have shown no sex dif-
ferences in absolute QTV59,115,121 with one exception.48 Two add-
itional reports showed increased VR 121 and altered QT-RR
dynamics in women.59 Lead-specific short-term SDQT in 12-lead
ECG suggests higher QTV in some leads in women.20 Larger studies
involving short-term ECG of .100 subjects demonstrated in-
creased SDQT, QTVN, and QTVi in women.52,123 There is thus
some evidence of a small sex effect, perhaps partly explainable by
differences in autonomic modulation.124
Pharmaceuticals
Only singular studies exist on drug effects. QT variability index in
ambulatory ECG in normal subjects was increased by pemoline
(dopaminergic) but unaltered by fluoxetine (selective serotonin re-
uptake inhibitor).125 Yohimbine decreased QTVi while clonidine
had no effect.126 Oestrogen replacement therapy did not affect
QT interval variability in body surface ECG Page 9 of 20
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QTV measures.127 Sotalol infusion increased QTVi,128,129 but pro-
panolol and amiodarone had no effect,98,128 whereas grapefruit,128
sildenafil,130 and sevoflurane increased QTVi, the latter in
children.131
QTc duration
Few studies have investigated the relationship between QTc and
QTV. Short-term variability of QT was not correlated with QTc
(Bazett formula) in normal subjects.132 Similarly, QTVi showed no
correlation with QT duration.133 In normal subjects, RMSDQT
was not correlated with QTc (Bazett and Fridericia formulae).134
SDQT measured in 24-h ECG showed only moderate correlation
with QTc.8 Thus, substantial correlation between QTV and QTc
is unlikely, although little data are available and the generic rate cor-
rection formulae may have produced unreliable results.
Circadian effects, age, and sex should be considered when conducting
QTV studies. The effects of drugs are poorly investigated, and focused in-
vestigations are needed. The relation between QTV and QTc warrants fur-
ther studies.
Clinical value of QT interval
variability assessment
General findings
QT interval variability has been studied in a wide range of clinical
settings (Figure 7). Based on meta-analysis of 45 and 23 studies, re-
spectively, involving 1954 and 1190 normal adults, average values of
QTVi and SDQT during rest are 21.6 and 3.3 ms, possibly some-
what elevated in infants and children. A substantial number of stud-
ies of patients with primarily ischaemic heart disease (1850 patients)
demonstrate consistently higher QTVi values, with a weighted aver-
age of 20.6. SDQT values obtained from 404 patients show a simi-
lar picture, with a weighted average of 7.3 ms. Collated data from
patients with other cardiac diseases show a less distinct increase
in QTVi and SDQT. QT variability index values of patients with
long QT syndromes (LQTS) are similar to the upper end of normal
subjects, although this might be different in probands and in asymp-
tomatic carriers. QT variability index values of patients with mental
disorders largely overlap with normal values, while QTVi values in
patients with diabetes and autonomic neuropathy spread widely
across studies.
Further meta-analyses of existing studies combined with the analysis of
large ECG databases are needed to establish normal QTV values.
QT interval variability in clinical
populations
Cardiac patients
QT variability index appears useful for ECG-based screening of
patients with coronary artery disease (CAD), left ventricular (LV)
hypertrophy, and/or LV systolic dysfunction.136
Coronary artery disease, myocardial infarction, and ischaemic
cardiomyopathy. SDQT was significantly increased in CAD without
prior myocardial infarction (MI).24 Ambulatory ECG
demonstrated increased QTVN and QTVi during acute
ischaemia.137 Decoupling of QTV from HRV was observed during
induced ischaemia.138 During acute ST-segment elevation, positive
troponin T was associated with increased SDQT.139
Twelve-lead ECG of patients with recent MI showed increased
SDQT in six leads.140 QT variability index in leads corresponding
to the infarct site were correlated with indices of LV dysfunction.19
The RR-independent component of QTV appeared increased141
and RTend complexity increased,
142 the latter being more pro-
nounced in LV dysfunction. Data from patients with implanted car-
dioverter defibrillator (ICD), CAD, and ischaemic cardiomyopathy
(ICM)-related CHF suggest an inverse relation between QTVi and
LV ejection fraction (LVEF).48,105,143,144 Post-MI patients with low
LVEF showed increased high frequency variability in RTend time ser-
ies compared with MI patients with LVEF . 40% and CAD patients,
despite comparable high-frequency HRV power, arguing for respira-
tory modulation of venous return and LV filling and changes in me-
chanoelectrical coupling.50 Age appears to have no influence on
QTVi in CHF,97,143 but its influence could be blurred by the impact
of other factors accompanying the development of CHF.
Post-MI patients on b-blocker therapy were reported to have
smaller SDQT in ambulatory ECG than patients on no b-blockers,
with values similar to normal subjects while HR was comparable.114
One-year b-blocker treatment of ICM-related CHF lowered
QTVi.145 Magnesium sulphate reduced QTVi in ICM-related CHF
patients, and the change in serum magnesium was inversely corre-
lated with QTVi.146 Sotalol and grapefruit tended to increase
QTVi in ICM-related CHF patients, while amiodarone had no ef-
fect.128 In ICM-related CHF, atorvastatin therapy reduced
SDQT.147 In mild ICM-related CHF, sildenafil increased QTVi.129
In decompensated CHF, mostly due to CAD, the Ca2+ sensitizer le-
vosimendan did not increase ambulatory SDQT, despite increasing
non-sustained VT.148 In primarily ICM-related CHF, ibutilide did not
affect QTVi during sinus rhythm, but increased it during random
atrial pacing.149
The QTV response to acute autonomic stimuli appears blurred in
cardiac patients. In CHF, QTVi was increased, but the response to
head-up tilt was impaired97,150 and acute b-blockade showed no
QTV effect.106 In post-MI patients, anger recall test did not affect
QTVi during b-blockade.144 In a canine model, however, increased
QTVi was observed with high sympathetic nerve activity after ex-
perimentally inducing heart failure,109 mirroring circadian auto-
nomic changes.151 Circadian variation in QTVi and QTVN and an
inverse correlation between QTVN and serum potassium were
shown in CHF patients.152 Exercise increased QTVi in patients
with ICD and documented CAD.104
CABG appears to acutely increase153 and later reduce QTVi.154
Similarly, SDQT increase was shown after cardiac surgery.135 In pa-
tients with structural heart disease and cardiac resynchronization
therapy, reverse electrical remodelling was associated with QTVN
reduction and coherence increase.155 Reduction in STVQT was ob-
served in cardiac patients following a rehabilitation programme.156
Hypertension and left ventricular hypertrophy. Increased QTVi was
seen in nocturnal blood pressure (BP) non-dippers,157
pre-hypertension,158 and hypertension.158 – 160 QT variability
index correlated with systolic BP158 and inversely correlated with
nocturnal BP reduction.157 Similarly, QTVN correlated with
resting systolic BP and cardiac norepinephrine spillover.160 In
M. Baumert et al.Page 10 of 20
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Figure 7 Reported values of QTVi (top) and SDQT (bottom). Data are presented as mean and standard deviations. The size of the circle in-
dicates sample size. (Two studies were excluded due to reported methodical differences in the QT interval extraction that lead to very small
SDQT values.)50,135
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hypertensive patients, the degree of hypertrophy correlated with
QTVi.159 SDQT also correlated with LV mass after renal
transplantation.161 In normal adults, QTVi was correlated with
cardiac output, e.g. stroke volume index and acceleration index.162
Hypertrophic cardiomyopathy and myotonic dystrophy. QT variability
index was increased and coherence reduced in hypertrophic
cardiomyopathy (HCM) caused by a b-myosin heavy chain
mutation.163 SDQT from ambulatory ECG was also increased in
HCM.164 The QTV part unexplained by HRV was useful for
screening of HCM patients.165 Further, QTVi was increased in
myotonic dystrophy Type 1.166 In primarily non-ICM, QTVi was
unrelated to LVEF,12 but related to the late gadolinium enhancement
in cardiac magnetic resonance imaging, a marker of disease severity
and arrhythmic risk.167
Long QT syndromes. Increased QTV has been repeatedly reported in
mixed LQTS cohorts of patients with different mutations,132 –
134,168,169 suggestive of a link between QTV and reduced
repolarization reserve. Cohorts that included Type 2 (and Type 3)
mutations showed consistently increased QTVi,133,168 root mean
square of QT interval differences,134 and STVQT.168 In LQTS Type
1, QTV changes appear less pronounced; intermediate STVQT
increases,168 and no differences in QTVi134 were reported. In
LQT1 patients, QTV levels seem to be associated with arrhythmic
risk.170 Increases in QTV in LQT1 may be evident only after
sympathetic stimulation.171 Measures of QTV were weakly
correlated with QTc interval duration at baseline133,134 or after
sympathetic stimulation171 or with uncorrected QT duration.132,168
In patients with drug-induced LQTS, documented TdP was
associated with increased STVQT in the absence of QT
prolongation.172
Other cardiac conditions. In paroxysmal atrial fibrillation (AF), VR was
reduced in AF periods compared with sinus rhythm.173 QTVi but
not QTvar was increased in amyloidosis of familial Mediterranean
fever.174 In Brugada syndrome, sodium channel blockade
increased already elevated SDQT in the right precordial leads.175
QT variability index was increased in children with acute Kawasaki
disease and correlated with temperature and C-reactive protein.176
Bariatric surgery reduced QTVi in morbidly obese subjects.177
Clinically relevant information may be derived from QTV in cardiac pa-
tients, despite unfavourable signal-to-noise ratios and measurement diffi-
culties. Large QTV datasets from cardiac patients with different
pathologies should be collected to explore relationships with clinical mar-
kers, clinical endpoints, and underlying mechanisms.
In large datasets, the presence or absence of measurable QRS varia-
tions should also be investigated so that primary and secondary QTV
sources can be distinguished.
Non-cardiac diseases
Mental disorders. Increased short-term QTVi in panic disorder (PD)
was repeatedly reported.54,126,178,179 Increased QTVi and QTvar
were also observed in children with anxiety disorders.180
Sympathetic changes appear to cause these changes. The
a2-adrenergic antagonist yohimbine increased anxiety as well as
QTVi, whereas a2-adrenergic agonist clonidine reduced QTVi in
PD.126 QT interval variability response to b1- and b2-activation
with isoprotenerol was pronounced in PD compared with normal
subjects.179 However, no correlations were observed between
resting cardiac norepinephrine spillover and QTVi.108 Treatment
with tricyclic antidepressant nortriptyline increased QTVi in PD,
whereas selective serotonin reuptake inhibitors had no
effect.108,181 Holter ECG analysis suggests increased QTVi in PD
during night time.113 QT variability index and QTVN were also
increased in major depressive disorder.54,182 Short-term
antidepressant treatment with serotonin and noradrenaline
reuptake inhibitors tended to increase QTVi.182 Correlation
analyses between anxiety and depression scores and QTVi
provided inconclusive results; positive,54 negative,108 and no
correlations182 were reported in major depressive disorder and
PD. In normal subjects, correlations between QTVi and anxiety
scores were reported.98 In patients with recent MI, depression was
associated with increased QTVi while QTVN was not different.183
Increased QTVi was also shown during the first episode of
neuroleptic-naive psychosis.184 QT variability index and QTVN
were increased in acute schizophrenia and QTVi correlated with
the degree of hallucinations and delusions.185 Increased QTVi was
also observed in unaffected first-degree relatives.186 Antipsychotic
treatment with olanzapine did not normalize QTVi.187
Increased QTVi correlating with serum potassium was reported
in anorexia nervosa.188 Treated anorexia nervosa with restored
weight and normal serum electrolytes showed normal QTVi.189
QT variability index was also found increased in alcoholics after
acute alcohol withdrawal, but was normal in abstained alcoholics.190
Cocaine increased QTVi in a dose-dependent relationship.191
Diabetes mellitus, autonomic neuropathy, spinal cord injury, and renal
failure. In Type 2 diabetes mellitus, increased QTVi correlated
with the degree of cardiovascular autonomic neuropathy,192,193
and cardiac sympathetic dysinnervation correlated with QTVN
during orthostatic activation.193 In chronic renal failure, diabetes
was associated with increased QTVi.194 In dilated
cardiomyopathy, however, QTVi was not different between
diabetic and non-diabetic patients.195
In familial dysautonomia, QTVi was reported significantly in-
creased,25 unchanged,196 or decreased;197 while QTV unrelated
to HRV was reported to be increased25,197 or unaltered.196
Increased QTVi was reported in spinal cord injury above T5 and
T6.198,199 While one study showed increased Tpeak–Tend variabil-
ity,198 another study showed no difference in QTVN.199 Among
spinal cord injury men, hypogonadism was associated with increased
QTVI,200 which reduced after testosterone replacement therapy200
that reduced coherence.201
QT interval variability changes in non-cardiac patients are likely linked
to autonomic and central nervous system effects. The pathways of QTV
regulation should be investigated together with investigations of whether
QTV could be used as a general marker of autonomic physiology and
derangement.
Likely clinical value
QT interval variability was repeatedly advocated for guiding ICD
therapy. Risk stratification studies that report hazard ratios are sum-
marized in Table 2. Analysis of prospectively collected short-term
ECG in MADIT II demonstrated both QTVi and QTVN predicting
appropriate VT/VF shocks.44 Sex-specific analysis showed predictive
value of intracardiac QTVN and QTVi for men, but not women, in
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Table 2 Hazard ratios of clinical studies on risk prediction based on QTV metrics
Study population N Follow-up (event rate) Variables Endpoint HR (95% CI)
Tereshchenko et al.202 Structural heart disease, ICD
(EF 33+12%)
298 16+8 months
17.4%
Highest QTVi quartile
(≥0.114)
ICD shock for VT/VF 4.18 (1.40–12.46)
Dobson et al.203 GISSI-HF CHF, NYHA II– IV
180 patients EF ≤ 35%
88 patients EF . 35%
268 47 months (median)
Total mortality 20%
CV death 16%
QTVi
(continuous)
Highest QTVi quartile
(more than 20.84)
Total mortality
CV death
Total mortality
CV death
4.4 (1.91.9–10.1)
4 (1.8–8.8)
2 (1.1–3.6)
2.1 (1.1–3.8)
Haigney et al.44 MADIT II History of MI and EF ≤ 30% 463 21+12 months
22.4%
Highest QTVi quartile
(more than 20.52)
Highest QTVN quartile
(.0.257)
ICD shock for VT/VF
ICD shock for VT/VF
1.8 (1.09–2.95)
2.18 (1.34–3.55)
Piccirillo et al.45 CHF due to post-ischaemic CM,
35, EF, 40 (37+ 1%) NYHA I
396 60 months
total mortality 11%
SCD 6%
.80th QTVi percentile
(more than or equal to
20.47)
QTVi (continuous)
.80th QTVN percentile
(≥0.24)
QTVN (continuous)
Total mortality
SCD
Total mortality
SCD
Total mortality
SCD
Total mortality
SCD
2.4 (1.2–4.9)
4.6 (1.5–13.4)
2.6 (1.3–5.2)
2.9 (1.3–6.5)
1.5 (0.4–5.3) (n.s.)
0.4 (0.07–1.8) (n.s.)
0.1 (0.0–1.8) (n.s.)
0.8 (1.0–14) (n.s.)
Perkiomaki et al.204 Consecutive patients with
decreased LV function and ICD
47 26+8 months
17% death
34% ICD shock/death
0.1 of ApEn of RTpeak ICD shock/ death 3.36 (1.28–8.83)
Segerson et al.205 Acute MI, EF 47+9% 678 63 months (mean)
19.7%
RTpeak: DI scatter standard
error
Death/documented ventr.
arrhythmia
2.5 (1.4–4.0)
Jensen et al.204 Acute MI
(EF 48 [24,60])
311 36 months
22.5%
0.1 of SDQT/SDNN Total mortality 1.9 (1.5–2.4)
Sredniawa et al.207 ICD patients implanted according
to ESC guidelines
155 22+12 months
11% major arrhythmic
cardiac event
SDQT 1 ms increase in
Holter ECG
Major arrhythmic cardiac
event
1.08 (1.05–1.08)
Tereshchenko et al.46 MUSIC CHF with ischaemic or
non-ischaemic CM
NYHA II–III
279 patients EF ≤ 35%
254 patients EF . 35%
533 44 months (median)
23.5% Total mortality
3.8% non-cardiac death
9.9% non-sudden CD
9.8% SCD
Highest QTVi quartile
(more than 21.19)
QTVN
CV death
Non-cardiac death
Non-sudden CD
SCD
CV death
Non-cardiac death
Non-sudden CD
SCD
1.67 (1.14–2.47)
n.s.
2.91 (1.69–5.01)
n.s.
n.s.
n.s.
n.s.
n.s.
Oosterhoff et al.41
(Data set from
Tereshchenko et al.202)
Structural heart disease, ICD 233 26+15 months
21%
Highest quartile STV ratio
(.0.88)
+highest QTVI quartile
(.0.14)
ICD shock for VT/VF or
SCD
1.8 (1.0–3.4)
2.4 (1.3–4.3)
Vrtovec et al.195 DCM, NYHA II–III, EF, 40% 132 12 months
6% CHF death
7.6% SCD
Highest QTVi quartile (no
numbers)
CHF death
SCD
1.06 (1.03–1.41)
1.07 (1.02–1.42)
HR, hazard ratio of multivariate models; EF, ejection fraction; NYHA, New York Heart Association class; SCD, sudden cardiac death; CHF, chronic heart failure; CV, cardiovascular; MI, myocardial infarction; DCM, dilated cardiomyopathy.
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whom reduced coherence was predictive.47 Predictive value of
QTVi and VR for appropriate VT/VF shock was also demonstrated
in a large study of patients with structural heart disease, impaired LV
function, and implanted ICD.41,202 QT variability index was higher in
patients on Class III antiarrhythmics, but carried independent risk
after drug effect adjustment.208 However, a smaller study in ICD pa-
tients with structural heart disease showed no significant intracar-
diac QTV increase in patients subsequently experiencing VT/
VF.209 Increased QTVi predicted VT and sudden cardiac death
(SCD) in patients undergoing electrophysiological study.42 In pa-
tients with a VT/VF history who also underwent electrophysiologic-
al study, QTVi was not predictive of ICD discharge, primarily caused
by VT but not VF.210 In patients with ICD implanted for SCD pre-
vention, increased SDQT in ambulatory ECG was associated with
major arrhythmic events.207
Retrospective analysis of the MUSIC study that enrolled patients
with NYHA Classes II– III showed predictive value of QTVi for car-
diovascular mortality but not for SCD.46 However, increased QTVi
predicted SCD in patients with dilated cardiomyopathy with NYHA
Class II– III and LVEF, 40%.195 QTVi predicted total and cardiovas-
cular mortality in ambulatory ECG of the GISSI-HF trial that inves-
tigated a heterogeneous group of NYHA Class II– IV CHF patients
with LVEF . 35%.203 Prospective analysis of asymptomatic CHF pa-
tients with ICM showed the predictive value of QTVi, but not
QTVN for SCD and total mortality.45 STVQT was found increased
in patients with non-ischaemic CHF and VT history.40 The complex-
ity of QT intervals was increased in ICD patients with decreased LV
function who died or experienced ICD shock.204 QT interval vari-
ability obtained from ambulatory ECG of acute MI patients were
also shown to predict mortality.205,206 In patients with old MI,
QTVi was increased in patients with documented VT/VF.43
In organic heart disease, no significant differences in QTVi were
observed in patients with and without a VT history.211 RT interval
spectra in ambulatory ECG were predictive of SCD in HCM.212
In survivors of unexplained cardiac arrest, QTVi and coherence
measured during rest and epinephrine challenge were not signifi-
cantly different from first-degree relatives of SCD victims.213
Despite the evidence of the association between mortality and
QTV, individual short- or long-term risk prediction for VT/VF ap-
pears to be challenging with commonly used measures.214,215 So-
phisticated analysis of joint RR and QT dynamics seems to allow
detecting repolarization instability preceding malignant ventricular
arrhythmia in patients with acute MI.216
Prospective studies on the predictive value of QTV are needed as part of
a multivariate risk stratification procedure in different well-defined
populations.
Future outlook
Methodical considerations
While dedicated computer programs for QTV measurement are
readily available, the current level QTV measurement standardiza-
tion is insufficient. Data acquisition requirements, minimum
signal-to-noise levels, recording duration, pre-processing modal-
ities, and beat and artefact rejection techniques require further in-
vestigation. A more systematic application of advanced signal
processing tools capable of dealing with non-linearities and transi-
ents is necessary to improve QTV reproducibility and to derive
more insightful QTV descriptors. In addition, systematic studies
should explore the link between QTV and variability of the T
wave morphology (of the entire T wave) as well as the signal beyond
the T wave end.
Physiological determinants
The physiological basis of QTV is currently insufficiently explored.
The QTV response to HR changes with respect to amplitude and
direction of HR variation requires further investigation. Studying
QT dynamics around the individual-specific QT-RR curvature in ex-
perimental and electrophysiological studies may provide additional
insight. Although evidence suggests that QTV may be useful for
quantifying relative changes in sympathetic ventricular outflow dur-
ing states of heightened activity, it remains to be established whether
QTV indices can be used to infer absolute values of sympathetic ac-
tivity in normal subjects or whether QTV magnitude correlates with
changes of sympathetic activity only. Future investigations should
differentiate neural control directed to the sinus node from that di-
rected to ventricles and research how this regulation contributes to
the coupling/decoupling between HRV and QTV. The relation be-
tween cellular APD variability and body surface QTV also requires
further studies.
Clinical applications
The pathophysiology of increased QTV is poorly understood, al-
though reduced repolarization reserve, causing more variable regu-
lation responses, may play a role. The relation between autonomic
dysfunction and QTV in cardiac patients is not well established. The
main clinical use of QTV may lie in SCD risk stratification. Although
several studies have demonstrated independent predictive value of
QTV, most of the evidence is based on retrospective data analyse.
Prospective trials are needed to prove the usefulness of QTV. Cut-
off values or hazard ratios need to be defined before QTV can be-
come an integral part of decision-making. Established clinical risk
markers may be combined to increase predictability. Advanced
measurement modalities such as composite multi-lead QTV assess-
ment or response to premature ventricular contractions may ad-
vance clinical utility.
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Appendix A: Linear time-invariant
QT interval variability modelling
Linear time-invariant classes of models are applied to the qt series de-
rived from the original QT series after mean removal. When the aim is
spectral analysis, the qt series is usually modelled as an autoregressive
process,27,34,61 i.e. the current qt value is described as a sum of previous
qt values weighted with constant coefficients plus a noise term, repre-
senting the unpredictable part of qt dynamics (nqt) and described as a
white process:
qt(i) = A˜qt−qt(z) · qt(i) + nqt(i),
where A˜qt−qt(z) = a1,qt−qt · z−1 + · · · + an,qt−qt · z−n is an all-zero poly-
nomial of order n and z21 represents the one-step delay operator in the
z-domain. The power density spectrum can then be obtained as follows:
PSDqt( f ) = Tl2qt
1
1 − A˜qt−qt(z)
∣∣∣∣∣
∣∣∣∣∣
2
z=e2pjfT
,
where T is the mean heart period and l2qt is variance of the zero-mean
white noise nqt. Non-parametric approaches based on Fourier trans-
form for the estimation of power spectral density have been utilized
as well especially in the first pioneering studies.26
More complex linear models have been exploited to describe the de-
pendence of qt on previous rr intervals and other physiological influ-
ences such as the direct effect of respiration (resp).34 For example,
qt(i) = A˜qt−qt(z) · qt(i) + Bqt−rr(z) · rr(i) + Bqt−resp(z) · resp(i) + 1qt(i),
where Bqt−rr(z) = b0,qt−rr + b1,qt−rr · z−1 + · · · + bn,qt−rr · z−n accounts
for the action of current and previous rr values on qt, Bqt−resp(z) =
b0,qt−resp + b1,qt−resp · z−1 + . . . + bn,qt−resp · z−n accounts for the influ-
ence of current and past resp samples on qt and 1qt is the noise affecting
qt dynamics.
Based on the model structure the qt-rr cross-spectrum, Cqt−rr(f ), and
the power spectra of rr and qt series, Sqt(f ) and Srr(f ), can be estimated
and the squared coherence can be computed as
K2qt−rr( f ) =
|Cqt−rr( f )|2
Sqt( f ) · Srr( f )
and the transfer function as
Hqt−rr( f ) = Cqt−rr( f )Srr( f ) .
Simpler model structures, such as the bivariate linear model with white
residuals,26,28,29,49 and non-parametric techniques26,28,29 were also
used. Examples of rr and qt series, Sqt(f ) and Srr(f ) power spectra,
squared coherence function between qt and rr series, K2qt−rr(f ), and
transfer function modulus, |Hqt−rr(f )|, are shown in Figures 3 and 4.
Although these modelling approaches can be utilized to estimate
QT–RR transfer function, and squared coherence, they have been pro-
posed with the main purpose to decompose QTV variability into partial
contributions due to the exogenous sources (Figure 5). Thus, this multi-
variate linear modelling approach separates the fraction of QTV that is
independent from RR and to quantify the genuine QTV.28,29,34 Residual
variance in QTV, not accounted for by these models, implicates factors
other than RR in QTV generation.34,61 The total of unexplained QTV
also depends on the approximation of the QT interval. The approxima-
tion of the QT interval by RTpeak led to smaller fractions of QTV
independent of RR variability compared with RTend.
23 Overall RTpeak
variance is also smaller than that of RTend.
23 The part of QTV that is un-
related to RR changes occurs primarily in the very low frequency range,
whereas the LF and HF oscillations are primarily driven by RR.29 Among
other factors, a part of RR-unrelated QTV depends on the autonomic
state34 and also modulates the QT–RR coupling strength.49 Since the
fraction of QTV unrelated to RR variations was shown to increase dur-
ing graded head-up tilt (Figure 5), it may be under sympathetic control.34
Uncoupling between QTV and RR variability at the respiratory rate was
also observed during graded head-up tilt (Figure 4). This may be caused
by the reduction in respiratory sinus arrhythmia due to vagal withdrawal
and/or progressively more complex respiratory effects on QTV.49
Linear multivariate modelling, estimating the transfer function sug-
gests that autonomic activity modulates gain and phase of QT–RR coup-
ling.29 Graded head-up tilt increased gain in the LF band and augmented
phase delay (Figure 4), while controlled breathing increased gain in the
HF band and attenuated phase delay.29 QT–RR gain functions derived
from multivariate linear models and accounting for exogenous sources
are less affected by noise sources than gain estimates obtained with
more traditional methods.29
Reduced ability of linear models to interpret QTV dynamics and its
relation to HRV may result from autonomically induced wave morph-
ology changes,217 the linear coupling decrease due to increasingly non-
linear QT–RR relationship, the underlying cardiac pathology,218 or the
presence of response with different time constants to RR variations. For
example, the fraction of QTV depending on HRV was found decreased
in post-MI patients.218 In some studies, the linear dependences were
non-linearly transformed to account for possible non-linear relations.70
Appendix B: Non-linear QT
interval variability analysis
Linear modelling may be insufficient to describe the interplay between
cardiac cycles and QT interval. While techniques specifically designed
for static measurement of the rate-corrected QT interval219,220 capture
slow trends in QT interval well, they tend to underestimate beat-to-beat
fluctuations. On the other hand, techniques commonly used to model
beat-to-beat variability (e.g. autoregressive models as discussed above),
approximate HF and LF oscillations closely but may not capture slow
trends well, as reflected in the lack of squared coherence in the very
low frequency range of QTV.29 Using linear models with separate esti-
mates of the rapid and slow component of QT rate-adaptation, close ap-
proximations of QTV were achieved in normal subjects during rest and
exercise.65
Several techniques from non-linear systems and information theory
have been used to capture non-linear QTV dynamics. Multi-scale en-
tropy and detrended fluctuation analyses showed significant differences
in the beat-to-beat dynamics of QT intervals compared with RR inter-
vals.204,221,222 Sample and approximate entropies were found to be
higher in QT than in RR time series.204,221 –223 QT interval time series
lack the scale invariance that is typical of RR time series.221 Further,
point-wise correlation dimension was higher in QT time series than in
RR time series.224 Largest Lyapunov exponent and embedding dimen-
sion225 were also utilized to quantify QTV complexity. Cross-
conditional entropy measuring the amount of information carried by
QT changes given RR variations219 (i.e. the genuine information carried
by QTV) and joint symbolic dynamics59,118 are among other techniques
that have been proposed to capture non-linear features in the QT-RR
relation. Recently, recurrence quantification and multi-fractal analyses
have been proposed as further tools to explore QT interval
dynamics.226,227
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